[A comparison of efficacy and safety between Chinese generic imatinib versus branded imatinib in patients with newly-diagnosed chronic myeloid leukemia in the chronic phase: a single-center prospective cohort study].

H X Shi, Y Z Qin, Yuni Lai, Xiao‐Jun Huang, Qian JiangPubMed 2016 · DOI

Abstract

<b>Objective:</b> To compare the efficacy and safety between Chinese generic imatinib (Xinwei<sup>®</sup>, Jiansu Hansoh Pharmaceutical Group Co., Ltd.) versus branded imatinib (Glivec<sup>®</sup>, Novartis) in patients with newly-diagnosed chronic myeloid leukemia in chronic phase (CML-CP). <b>Methods:</b> Patients with newly diagnosed CML-CP were enrolled and assigned to receive either Xinwei or Glivec at an initial dose of 400 mg/d according to patients' financial capability. The efficacy and adverse effects were evaluated. <b>Results:</b> From January 2014 to September 2015, 145 eligible patients were assigned to Xinwei (<i>n</i>=89) or Glivec (<i>n</i>=56) group. All patients were treated and followed up at least 3 months. At 3 months, the complete response rates were 95.5%(85/89) and 100%(56/56), major cytogenetic response rates were 74.2%(66/89) and 80.4%(45/56), and the proportions of achieving BCR-ALB<sup>IS</sup>≤10% were 76.1%(67/88) and 82.1%(46/56) in Xinwei and Glivec groups respectively (all <i>P</i>>0.05). With a median follow-up of 12 months, 2 patients in each group progressed to accelerate or blast phase. Hematologic and non-hematologic side effects were similar between the 2 groups. <b>Conclusions:</b> Early hematological, cytogenetic and molecular responses between Xinwei and Glivec are comparable in newly-diagnosed CML-CP patients. The progression rate and side effects are also similar between the 2 groups.
BibTeX
@inproceedings{shi2016comparison,
  author = {H X Shi and Y Z Qin and Yuni Lai and Xiao‐Jun Huang and Qian Jiang},
  title = {{[A comparison of efficacy and safety between Chinese generic imatinib versus branded imatinib in patients with newly-diagnosed chronic myeloid leukemia in the chronic phase: a single-center prospective cohort study].}},
  booktitle = {PubMed},
  year = {2016},
  doi = {10.3760/cma.j.issn.0578-1426.2016.12.003},
}

Loading related content...

Figure